A decision-making tool for a costly innovative technology the Case of Carbon Ion Radiotherapy

Journal d'Economie Medicale

Volumn 25, Issue 7-8, 2007, Pages 367-380

  Perrier, L ^a,b   Combs, S E ^c   Auberger, T ^d   Zucca, L ^e   Naslund I ^f   Pijls Johannesma, M ^g   Rochat, J ^h   Lievens, Y ⁱ   Gueye, N D ^h   Heeren, G ^j   Pommier, P ^k  

^a GATE Lyon Saint Etienne   (France)

^b UNIVERSITÉ LUMIÈRE LYON 2   (France)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^e TERA Foundation   (Italy)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITÉ LYON 1   (France)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^j European Society for Therapeutic Radiology and Oncology   (Belgium)

^k CENTRE LÉON BÉRARD   (France)

more..

Author keywords

Cancer; Carbon ion; Cost; Innovation; Radiotherapy

Indexed keywords

EID: 41449089844     PISSN: 02940736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Schulz-Ertner D, Nikoghosyan A, Didinger B et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer, 2005, 104, 338-44.
2. Orecchia R, Zurlo A, Loasses A et al. Particle beam therapy (hadrontherapy): basis for interest and clinical experience. Eur J Cancer, 1998, 34, 459-68.
3. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients, Int J Radiat Oncol Biol Phys, 2004, 60, 186-96.
4. Zietman AL, DeSilvio ML, Slater JD et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA, 2005, 294, 1233-9.
5. Kamada T, Tsujii H, Tsuji H et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol, 2002, 15, 4466-71.
6. Miyamoto T, Yamamoto N, Nishimura H et al. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol, 2003, 66, 127-40.
7. Schultz-Ertner D, Haberer T, Jäkel O et al. Radiotherapy for chordomas and low-grade chondrosarcomas of the skull base with carbon ions. Int J Radiât Oncol Biol Phys, 2002, 53, 36-42.
8. Schultz-Ertner D, Nikoghosyan A, Thilmann C et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys, 2004, 58, 631-40.
9. Schulz-Ertner D, Nikoghosyan A, Didinger B, Debus J. Carbon ion radiation therapy for chordomas and low grade chondrosarcomas - current status of the clinical trials at GSI. Radiother Oncol, 2004, 73, S53-6.
10. Tsuji H, Yanagi T, Ishikawa H et al. Hypofractionated radiotherapy with carbon ion beams for prostate cancer. Int J Radiât Oncol Biol Phys, 2005, 63, 1153-60.
11. Tsujii H, Mizoe JE, Kamada T et al. Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol, 2004, 73, S41-9.
12. Bajard M, De Conto JM, Remillieux J et al. Status of the "ETOILE" project for a French hadrontherapy centre. Radiother Oncol, 2004, 73, S211-5.
13. Griesmayer E, Auberger T. The status of MedAustron. Radiother Oncol, 2004, 73, S2025.
14. Haberer T, Debus J, Eickhoff H et al. The Heidelberg Ion Therapy Center. Radiother Oncol, 2004, 73, S186-90.
15. Amaldi U. CNAO: The Italian Centre for light ion therapy. Radiother Oncol, 2004, 73, S191-201
16. LambinP,Fekkers H, Daniels E et al. Business plan for an Euroregional ion therapy institute. Maastricht: Maastro clinic. 2005.
17. Drummond MF, Sculpher MJ, O'Brien BJ et al. Methods for the Economic Evaluation of Health care programmes. Oxford University Press: Oxford. 2005.
18. Ishikawa H, Tsuji H, Tsujii H. Clinical experience of carbon ion radiotherapy for malignant tumors. Gan To Kagaku Ryoho, 2006, 33, 444-9.
19. Koto M, Miyamoto T, Yamamoto N et al. Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol, 2004, 71, 147-156.
20. Nishimura H, Miyamoto T, Yamamoto N et al. Radiographic pulmonary and pleural changes after carbon ion irradiation. Int J Radiat Oncol Biol Phys, 2003, 55, 861-866.
21. Fang LC, Komaki R, Allen P, Guerrero T, Mohan R, Cox JD. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys, 2006, 66, 108-16.
22. Nyman, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer, 2006, 51, 97-103.
23. Akakura K, Tsujii H, Morita S et al. Phase I/II clinical trials of carbon ion therapy for prostate cancer. Prostate, 2004, 58, 252-258.
24. Ishikawa H, Tsuji H, Kamada T et al. Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer. Int J Radiat Oncol Biol Phys, 2006, 66, 1084-1091.
25. Ishikawa H, Tsuji H, Kamada T et al. Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study. Radiother Oncol, 2006, 81, 57-64.
26. Goitein M, Jermann M. The relative costs of proton and X-ray radiation therapy. Clinical Oncology, 2003, 15, 37-50.
27. Tsujii H, Mizoe J, Kamada T. Clinical results of carbon ion radiotherapy at NIRS. J Radiat Res, 2007, 48, A1-A13.
28. Schultz-Ertner D, Karger CP, Feuerhake A et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys, 2007, 68, 449-57.
29. Jäkel O, Land B, Combs SE, Schultz-Ertner D, Debus J. et al. On the cost-effectiveness of carbon ion radiotherapy for skull base chordoma. Radiother Oncol, 2007, 83, 133-8.